These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16565390)

  • 1. Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitis.
    Liao T; Ke Y; Shao WH; Haribabu B; Kaplan HJ; Sun D; Shao H
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1543-9. PubMed ID: 16565390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells.
    Shao H; Liao T; Ke Y; Shi H; Kaplan HJ; Sun D
    Exp Eye Res; 2006 Feb; 82(2):323-31. PubMed ID: 16125173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of established experimental autoimmune uveitis by anti-LFA-1alpha Ab.
    Ke Y; Sun D; Zhang P; Jiang G; Kaplan HJ; Shao H
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2667-75. PubMed ID: 17525198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
    Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
    Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis.
    Peng Y; Han G; Shao H; Wang Y; Kaplan HJ; Sun D
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4153-61. PubMed ID: 17724201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene B4 promotes neovascularization and macrophage recruitment in murine wet-type AMD models.
    Sasaki F; Koga T; Ohba M; Saeki K; Okuno T; Ishikawa K; Nakama T; Nakao S; Yoshida S; Ishibashi T; Ahmadieh H; Kanavi MR; Hafezi-Moghadam A; Penninger JM; Sonoda KH; Yokomizo T
    JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The leukotriene B
    Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
    Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene B
    Eskandarpour M; Chen YH; Nunn MA; Coupland SE; Weston-Davies W; Calder VL
    Am J Pathol; 2021 Feb; 191(2):320-334. PubMed ID: 33159884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells.
    Shao H; Fu Y; Liao T; Peng Y; Chen L; Kaplan HJ; Sun D
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):596-603. PubMed ID: 15671287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
    Avichezer D; Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):127-31. PubMed ID: 10634611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis.
    Hara Y; Caspi RR; Wiggert B; Chan CC; Streilein JW
    Curr Eye Res; 1992; 11 Suppl():97-100. PubMed ID: 1424755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
    Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
    Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.
    Cortes LM; Mattapallil MJ; Silver PB; Donoso LA; Liou GI; Zhu W; Chan CC; Caspi RR
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1946-56. PubMed ID: 18436827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interphotoreceptor retinoid-binding protein (IRBP)-deficient C57BL/6 mice have enhanced immunological and immunopathogenic responses to IRBP and an altered recognition of IRBP epitopes.
    Avichezer D; Liou GI; Chan CC; Lewis GM; Wiggert B; Donoso LA; Nickerson JM; Crawford MA; Caspi RR
    J Autoimmun; 2003 Nov; 21(3):185-94. PubMed ID: 14599843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The leukotriene B4 receptor (BLT1) is required for effector CD8+ T cell-mediated, mast cell-dependent airway hyperresponsiveness.
    Taube C; Miyahara N; Ott V; Swanson B; Takeda K; Loader J; Shultz LD; Tager AM; Luster AD; Dakhama A; Gelfand EW
    J Immunol; 2006 Mar; 176(5):3157-64. PubMed ID: 16493075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of interphotoreceptor retinoid-binding protein (IRBP)-specific Th1 and Th17 cells in anterior chamber-associated immune deviation (ACAID).
    Cui Y; Shao H; Sun D; Kaplan HJ
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5811-7. PubMed ID: 19458338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotriene B₄-leukotriene B₄ receptor axis promotes oxazolone-induced contact dermatitis by directing skin homing of neutrophils and CD8⁺ T cells.
    Lv J; Zou L; Zhao L; Yang W; Xiong Y; Li B; He R
    Immunology; 2015 Sep; 146(1):50-8. PubMed ID: 25959240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.